Agenus Inc. logo

Agenus Inc.

NASDAQ:AGEN

Overview | Financials
Company Name Agenus Inc.
Symbol AGEN
Currency USD
Price 2.83
Market Cap 66,388,687
Dividend Yield 0%
52-week-range 2.5 - 19.69
Industry Biotechnology
Sector Healthcare
CEO Dr. Garo H. Armen Ph.D.
Website https://www.agenusbio.com

An error occurred while fetching data.

About Agenus Inc.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon

Related Stocks

Accolade, Inc. logo

Accolade, Inc.

ACCD

3.48 USD

IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

IDYA

25.61 USD

Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc.

INO

1.84 USD

MiMedx Group, Inc. logo

MiMedx Group, Inc.

MDXG

9.1 USD

Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc

CNTA

17.16 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

15.64 USD

ADMA Biologics, Inc. logo

ADMA Biologics, Inc.

ADMA

17.4 USD

Financials

Numbers are in millions USD

Numbers are in millions USD